[go: up one dir, main page]

DK0817646T3 - Fremgangsmåder til behandling af inflammation og præparater derfor - Google Patents

Fremgangsmåder til behandling af inflammation og præparater derfor

Info

Publication number
DK0817646T3
DK0817646T3 DK96909862T DK96909862T DK0817646T3 DK 0817646 T3 DK0817646 T3 DK 0817646T3 DK 96909862 T DK96909862 T DK 96909862T DK 96909862 T DK96909862 T DK 96909862T DK 0817646 T3 DK0817646 T3 DK 0817646T3
Authority
DK
Denmark
Prior art keywords
methods
serp
preparations
compositions
biologically active
Prior art date
Application number
DK96909862T
Other languages
English (en)
Inventor
D Grant Mcfadden
Alexandra Lucas
Original Assignee
Viron Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viron Therapeutics Inc filed Critical Viron Therapeutics Inc
Application granted granted Critical
Publication of DK0817646T3 publication Critical patent/DK0817646T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96909862T 1995-03-27 1996-03-26 Fremgangsmåder til behandling af inflammation og præparater derfor DK0817646T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/411,043 US5939525A (en) 1995-03-27 1995-03-27 Methods of treating inflammation and compositions therefor
PCT/US1996/004054 WO1996030042A2 (en) 1995-03-27 1996-03-26 Methods of treating inflammation and compositions therefor

Publications (1)

Publication Number Publication Date
DK0817646T3 true DK0817646T3 (da) 2003-04-22

Family

ID=23627329

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96909862T DK0817646T3 (da) 1995-03-27 1996-03-26 Fremgangsmåder til behandling af inflammation og præparater derfor

Country Status (11)

Country Link
US (2) US5939525A (da)
EP (1) EP0817646B1 (da)
JP (1) JPH11503122A (da)
AT (1) ATE230609T1 (da)
AU (1) AU5323396A (da)
CA (1) CA2214988A1 (da)
DE (1) DE69625682T2 (da)
DK (1) DK0817646T3 (da)
ES (1) ES2187646T3 (da)
PT (1) PT817646E (da)
WO (1) WO1996030042A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP508798A0 (en) * 1998-08-05 1998-08-27 Biotech Australia Pty Limited Method of treating psoriasis
CA2385312C (en) * 1999-10-27 2012-02-07 Alexandra Lucas Compositions and methods for preventing and treating transplant rejection
WO2001039790A1 (en) * 1999-12-02 2001-06-07 Viron Therapeutics, Inc. Methods of treating inflammation and compositions therefor
EP1313498A4 (en) * 2000-05-25 2004-04-21 Ben-Tsion Williger PHOSPHOLIPASE D EFFECTORS FOR THERAPY AND SCREENING
WO2002026245A2 (en) * 2000-09-29 2002-04-04 Zhong Z Robert Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
CA2424983A1 (en) * 2000-10-11 2002-04-18 Viron Therapeutics, Inc. Nucleic acid molecules and polypeptides for immune modulation
DK1339737T3 (da) * 2000-12-04 2007-10-15 Viron Therapeutics Inc Immunomodulatorisk protein dannet ud fra Yaba-abetumorvirus
US7718368B2 (en) * 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
JP2005500254A (ja) * 2001-03-05 2005-01-06 トランス　テック　ファーマ，インコーポレイテッド 治療因子としてのカルボキサミド誘導体
AU2002368225A1 (en) * 2001-10-10 2004-05-04 Mount Sinai School Of Medicine Of The City University Of New York Viral interferon antagonists and uses therefor
GB0125594D0 (en) * 2001-10-25 2001-12-19 Univ Sheffield Inhibitors for inactivating allergens
AU2003280252A1 (en) * 2002-11-01 2004-05-25 Alexandra R. Lucas Viral serpin regulation of inflamation
US7285530B2 (en) * 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
US8251876B2 (en) 2008-04-22 2012-08-28 Hill-Rom Services, Inc. Breathing exercise apparatus
US9180271B2 (en) 2012-03-05 2015-11-10 Hill-Rom Services Pte. Ltd. Respiratory therapy device having standard and oscillatory PEP with nebulizer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206017A (en) * 1986-06-03 1993-04-27 Incyte Pharmaceuticals, Inc. Use of protease nexin-I as an antiinflammatory
ES2096665T3 (es) * 1990-10-16 1997-03-16 John Lezdey Tratamiento de la inflamacion.
WO1992022320A1 (en) * 1991-06-14 1992-12-23 Genentech, Inc. C1 inhibitor variants and treating inflammatory response with c1 inhibitor
DE4214215A1 (de) * 1992-04-30 1993-11-04 Behringwerke Ag Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen
ATE219943T1 (de) * 1994-04-08 2002-07-15 Viron Therapeutics Inc Antirestenoses protein

Also Published As

Publication number Publication date
DE69625682D1 (de) 2003-02-13
DE69625682T2 (de) 2003-10-02
US5939525A (en) 1999-08-17
PT817646E (pt) 2003-04-30
CA2214988A1 (en) 1996-10-03
ATE230609T1 (de) 2003-01-15
JPH11503122A (ja) 1999-03-23
ES2187646T3 (es) 2003-06-16
AU5323396A (en) 1996-10-16
WO1996030042A2 (en) 1996-10-03
EP0817646B1 (en) 2003-01-08
US5917014A (en) 1999-06-29
EP0817646A2 (en) 1998-01-14
WO1996030042A3 (en) 1996-11-21

Similar Documents

Publication Publication Date Title
DK0817646T3 (da) Fremgangsmåder til behandling af inflammation og præparater derfor
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
EP1007556A4 (en) TROPONIN SUB-UNITS AND FRAGMENTS FOR USE AS INHIBITORS OF ANGIOGENESIS
DK0964690T3 (da) Peptid-lipidkonjugater, liposomer og liposomal lægemiddeladministration
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
SE8501050D0 (sv) Biologically active fragments of human antihemophilic factor and method for preparation thereof
DK1003546T3 (da) Fremgangsmåde til behandling af patienter ramt af dissemineret sklerose ved anvendelse af konsensus interferon
DK0914144T3 (da) Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi
PT902789E (pt) Derivados de androsteno
FI971420A (fi) Menetelmä diabetes mellituksen hoitamiseksi KGF:ää käyttämällä
AU9157901A (en) Methods of treating inflammatory and immune reactions and compositions therefor
SE9603725D0 (sv) New teatment
DK0661987T3 (da) Morphogeninduceret leverregeneration
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
DE69739482D1 (de) Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
TR199801801T2 (xx) Madde k�t�ye kullan�m�n�n tedavisi.
DK0644768T3 (da) Fremgangsmåder og præparater til inhibering af endotelcelle- og fibrinogenfremkaldt inflammation
MY109685A (en) Method for treating hepatitis b carriers with minimal disease